Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹59.8 Cr -5.3% -6.9% -44.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,248.1 Cr -7.4% -13.5% -2.1% Stock Analytics
KIRI INDUSTRIES ₹2,314.2 Cr -11.3% -22.9% -21.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,505.1 Cr -1.2% -4.8% -24.5% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹968.4 Cr -2.8% -11.7% 0.3% Stock Analytics
BODAL CHEMICALS ₹554.0 Cr -5.3% -14.3% -14.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-5.3%

-6.9%

-44.6%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses